(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of 2.63% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.79%.
Alector's revenue in 2026 is $21,045,000.On average, 10 Wall Street analysts forecast ALEC's revenue for 2026 to be $2,748,911,168, with the lowest ALEC revenue forecast at $1,297,863,953, and the highest ALEC revenue forecast at $3,795,148,435. On average, 9 Wall Street analysts forecast ALEC's revenue for 2027 to be $2,617,248,608, with the lowest ALEC revenue forecast at $1,297,863,953, and the highest ALEC revenue forecast at $3,598,151,228.
In 2028, ALEC is forecast to generate $2,516,046,122 in revenue, with the lowest revenue forecast at $1,297,863,953 and the highest revenue forecast at $3,181,201,397.